The Interleukin-11 Receptor α as a Candidate Ligand-Directed Target in Osteosarcoma: Consistent Data from Cell Lines, Orthotopic Models, and Human Tumor Samples
Published version of a preprint
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The interleukin-11 receptor α (IL-11Rα) is a functional target in bone metastasis. However, its role in primary bone tumors has not been established. As such, here, we evaluated IL-11Rα as a candidate target in primary and metastatic human osteosarcoma. First, in an orthotopic mouse model, we showed that IL-11Rα protein is markedly expressed in primary osseus and pulmonary metastatic osteosarcoma but absent from control normal tibia and lung. Moreover, systemic administration of an IL-11Rα–targeting phage displaying the cyclic nonapeptide CGRRAGGSC resulted in strong and selective accumulation of IL-11Rα–homing phage particles in the osteosarcoma but not in several control organs. Finally, IL-11Rα expression in a large panel of human primary and metastatic osteosarcoma samples was remarkably consistent with the observations in the orthotopic mouse model. These data establish IL-11Rα as a candidate target in human osteosarcoma and provide leads for the development of novel imaging and therapeutic agents for the management of this malignant tumor. [Cancer Res 2009;69(5):1995–9]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of IL-11Rα was found in several cancer types, including osteosarcoma [122].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [122]
In the citing paper
“Zhang et al. conducted the third-generation CAR-T cells targeting B7-H3 and proved the killing effects for tumor cells in vitro and in vivo using the patientderived xenografts (PDXs) model of osteosarcoma [116–125].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [122]
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597 · cited 1×
“On an unrelated line of evidence, IL-11/IL-11Ra binding and downstream signaling via signal transduction and activator of transcription 3 activation has been proposed as a leading molecular pathway in metastasis (18).”
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Self-citationPhenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,750 · cited 1×
“Molecular heterogeneity of the vascular endothelium enables selective targeting of agents to normal or diseased tissues (10, 11).”
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255690.03436.ae · Cited by 1,257 · cited 1×
“Molecular heterogeneity of the vascular endothelium enables selective targeting of agents to normal or diseased tissues (10, 11).”
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744 · cited 1×
“As previously well established (26, 27), phage were identified in the spleen and liver, which are part of the reticuloendothelial system that nonspecifically clear phage”
Self-citationSteps toward mapping the human vasculature by phage display
Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó-Vila, M., Giordano, R. J., Mintz, P. J., Ardelt, P. U., Yao, V. J., Vidal, C. I., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-121 · Cited by 607 · cited 1×
“This IL-11 mimic peptide bound the IL-11 receptor a (IL-11Ra), through a previously unrecognized binding site (16), and localized to the vasculature of human prostate cancer (13).”
Self-citationReversal of obesity by targeted ablation of adipose tissue
Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004) · Nature Medicine · doi:10.1038/nm1048 · Cited by 601
Self-citationJones, S. E., & Salmon, S. E. (1990) · Medical Entomology and Zoology · Cited by 532
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R., & Ruoslahti, E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3008 · Cited by 457 · cited 1×
“As previously well established (26, 27), phage were identified in the spleen and liver, which are part of the reticuloendothelial system that nonspecifically clear phage”
Self-citation
Cited by
Targeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Advances on immunotherapy for osteosarcoma
Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270
“The overexpression of IL-11Rα was found in several cancer types, including osteosarcoma [122].”
BackgroundIL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets
Unver, N., & McAllister, F. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.04.004 · Cited by 238
Ligand-targeted theranostic nanomedicines against cancer
Yao, V. J., D'Angelo, S., Butler, K. S., Theron, C., Smith, T. L., Marchiò, S., Gelovani, J. G., Sidman, R. L., Dobroff, A. S., Brinker, C. J., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.002 · Cited by 195
Self-citationMore than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
Putoczki, T., & Ernst, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410226 · Cited by 147
Metadata
- Authors
- Lewis, V. O., Ozawa, M. G., Deavers, M. T., Wang, G., Shintani, T., Arap, W., & Pasqualini, R.
- Affiliations
- 1Section of Orthopedic Oncology, Department of Surgical Oncology,
- 2David H. Koch Center, and Departments of
- Baylor College of Medicine (US)
- The University of Texas MD Anderson Cancer Center (US)
- ORCID
- Venue
- Cancer Research
- Published
- 2009-03-01
- Volume
- 69
- Issue
- 5
- Pages
- 1995-1999
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2050858874
- Cited by
- 79
- References
- 27
- Citations by year
- 2026: 3 · 2024: 8 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 7 · 2015: 7 · 2014: 4 · 2013: 5 · 2012: 5
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- osteosarcoma, bone metastasis, phage display, tumor imaging, orthotopic mouse model, lung metastasis, primary bone tumors
- MeSH terms
- Animals, Bone Neoplasms, Humans, Ligands, Lung Neoplasms, Male, Osteosarcoma, Cell Line, Tumor, Mice, Interleukin-11 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Interleukin-11 Receptor α as a Candidate Ligand-Directed Target in Osteosarcoma: Consistent Data from Cell Lines, Orthotopic Models, and Human Tumor Samples. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-4845
- The paper
- Lewis, V. O., Ozawa, M. G., Deavers, M. T., Wang, G., Shintani, T., Arap, W., & Pasqualini, R. (2009). The Interleukin-11 Receptor α as a Candidate Ligand-Directed Target in Osteosarcoma: Consistent Data from Cell Lines, Orthotopic Models, and Human Tumor Samples. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-4845
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.